Details of the Drug Inactive Ingredient (DIG)
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG | ||||||
---|---|---|---|---|---|---|
ICD Disease Classification 05 | Endocrine/nutritional/metabolic disease | Click to Show/Hide | ||||
Trientine
|
API Info |
Hyperphosphatemia [ICD-11: 5C64]
|
[1] | |||
ICD Disease Classification 06 | Mental/behavioural/neurodevelopmental disorder | Click to Show/Hide | ||||
Fluoxetine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[2] | |||
Sertraline
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[3] | |||
ICD Disease Classification 11 | Circulatory system disease | Click to Show/Hide | ||||
Disopyramide
|
API Info |
Ventricular tachyarrhythmia [ICD-11: BC71]
|
[4] | |||
ICD Disease Classification 15 | Musculoskeletal/connective-tissue disease | Click to Show/Hide | ||||
Tofacitinib
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[5] | |||
ICD Disease Classification 16 | Genitourinary system disease | Click to Show/Hide | ||||
Oxybutynin
|
API Info |
Overactive bladder [ICD-11: GC50]
|
[6] | |||
Full List of Biological Targets of DIG (DBTs) Regulated by This DIG | ||||||
---|---|---|---|---|---|---|
Cell line (CELL) | ||||||
DBT Name: Leukemia MT4 cells (MT4) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 1288.25 nM (estimated based on the structural similarity with CHEMBL202316 ) | [7] | ||||
Structural Similarity | Tanimoto coefficient = 0.78807947 | |||||
Tested Species | Homo sapiens (Human) | |||||
Cellosaurus ID | CVCL_2632 | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.